Guggenheim Reiterates Buy on Eli Lilly, Maintains $1183 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 88.8%

Neg 0% Neu 88.8% Pos 0%

Guggenheim analyst Seamus Fernandez reiterates Eli Lilly (NYSE:LLY) with a Buy and maintains $1183 price target.

Comments

No comments yet. Be the first!